INS and type 2 diabetes mellitus: PEG-Loxe tellingly inhibits β-cell apoptosis arguably by restoring the Bcl-2/Bax balance, blocking the endogenous apoptotic pathway, promoting the recovery of islet structural breakdowns and functional defects, and increasing insulin secretion for the effective treatment of T2DM.